BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1425 related articles for article (PubMed ID: 28919734)

  • 21. The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD.
    Kerti M; Balogh Z; Kelemen K; Varga JT
    Int J Chron Obstruct Pulmon Dis; 2018; 13():717-724. PubMed ID: 29535512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.
    Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T
    Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.
    Kitaguchi Y; Fujimoto K; Hanaoka M; Honda T; Hotta J; Hirayama J
    Int J Chron Obstruct Pulmon Dis; 2014; 9():805-11. PubMed ID: 25114520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease.
    Zafar MA; Tsuang W; Lach L; Eschenbacher W; Panos RJ
    Lung; 2013 Apr; 191(2):177-82. PubMed ID: 23283384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema.
    Ando K; Sekiya M; Tobino K; Takahashi K
    Lung; 2013 Dec; 191(6):585-91. PubMed ID: 24085320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for FEV
    Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function.
    Occhipinti M; Paoletti M; Bigazzi F; Camiciottoli G; Inchingolo R; Larici AR; Pistolesi M
    Radiology; 2018 May; 287(2):683-692. PubMed ID: 29361243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study.
    Cui L; Ji X; Xie M; Dou S; Wang W; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2823-2830. PubMed ID: 29033563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of emphysema with preoperative computed tomography has stronger association with pulmonary complications than pulmonary function test results after pulmonary lobectomy.
    Na KJ; Kang CH; Jeon JH; Seong YW; Park IK; Goo JM; Kim YT
    J Thorac Cardiovasc Surg; 2014 Mar; 147(3):915-20. PubMed ID: 24412255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart Rate Recovery After 6-min Walking Test Predicts Acute Exacerbation in COPD.
    Rodríguez DA; Kortianou EA; Alison JA; Casas A; Giavedoni S; Barberan-Garcia A; Arbillaga A; Vilaró J; Gimeno-Santos E; Vogiatzis I; Rabinovich R; Roca J
    Lung; 2017 Aug; 195(4):463-467. PubMed ID: 28624883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiopulmonary exercise test and PaO
    Skjørten I; Hilde JM; Melsom MN; Hisdal J; Hansteen V; Steine K; Humerfelt S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():91-100. PubMed ID: 29339921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computer quantification of "angle of collapse" on maximum expiratory flow volume curve for diagnosing asthma-COPD overlap syndrome.
    Wang W; Xie M; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3015-3022. PubMed ID: 27942211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P
    COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative CT Analysis in Patients with Pulmonary Emphysema: Do Calculated Differences Between Full Inspiration and Expiration Correlate with Lung Function?
    Song L; Leppig JA; Hubner RH; Lassen-Schmidt BC; Neumann K; Theilig DC; Feldhaus FW; Fahlenkamp UL; Hamm B; Song W; Jin Z; Doellinger F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1877-1886. PubMed ID: 32801683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of emphysema distribution on pulmonary function parameters in COPD patients.
    Bastos HN; Neves I; Redondo M; Cunha R; Pereira JM; Magalhães A; Fernandes G
    J Bras Pneumol; 2015; 41(6):489-95. PubMed ID: 26785956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease.
    Jenkins S; Čečins N
    Intern Med J; 2011 May; 41(5):416-22. PubMed ID: 20059599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
    Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
    J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.